Refractory Low Grade Non-Hodgkin's Lymphoma (NHL)

DrugDrug NameDrug Description
DB00073RituximabA monoclonal anti-CD20 antibody used to treat non-Hodgkin's lymphoma, chronic lymphocytic leukemia, Wegener's granulomatosis, pemphigus vulgaris, and rheumatoid arthritis.
DrugDrug NameTargetType
DB00073RituximabB-lymphocyte antigen CD20target
DrugDrug NamePhaseStatusCount